AVDL 250117 17.50P (AVDL250117P17500) Stock Options, News & Quotes

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US OptionsDetailed Quotes

AVDL250117P17500

Watchlist

7.10
0.000.00%

15min DelayTrading Dec 30 13:37 ET

0.00High0.00Low

Intraday

5D
Daily

News

Avadel Pharmaceuticals to Provide a Corporate Update and Preliminary Fourth Quarter and Full Year 2024 Financial Highlights on January 8
GlobeNewswireJan 3 08:00 ET
C-Suite Buy of the Week: Unusual Insider Trading Trends as 2025 Approaches
BenzingaDec 19, 2024 15:03 ET
Several Insiders Invested In Avadel Pharmaceuticals Flagging Positive News
Simply Wall StDec 13, 2024 07:22 ET
Independent Non-Executive Chairman of the Board of Avadel Pharmaceuticals Picks Up 16% More Stock
Yahoo FinanceDec 12, 2024 05:06 ET
Avadel Pharmaceuticals Announces Publication of Findings on Sodium Oxybate
TipRanksDec 11, 2024 08:21 ET
Avadel Pharmaceuticals Presents Results From Social Listening Analysis And Survey Of People With Narcolepsy Uncover Real-Life Challenges With Twice-Nightly Oxybate Therapy
BenzingaDec 11, 2024 08:17 ET

Comments

Tonyco

Dec 12, 2024 22:59

$Avadel Pharmaceuticals (AVDL.US)$
yeah, cluster buys drew my attention too

Trytosaveabit

Dec 12, 2024 04:27

A few new insider buys

$Avadel Pharmaceuticals (AVDL.US)$

Trytosaveabit

Dec 11, 2024 07:20

Hmm? Update

$Avadel Pharmaceuticals (AVDL.US)$ Avadel Pharmaceuticals Presents Results From Social Listening Analysis And Survey Of People With Narcolepsy Uncover Real-Life Challenges With Twice-Nightly Oxybate Therapy; Findings Published In 'Brain Sciences' Showed Missed Doses And Potential For Injury When Waking To Take A Second Dose Among The Key Challenges
– Findings published in Brain Sciences showed missed doses and potential for injury when waking to take a second dose among the key challen...

Stock_Drift

Oct 31, 2024 12:19

Unusual Volume Ticks. 1:18pm 🎃

$Roblox (RBLX.US)$ $Anavex Life Sciences (AVXL.US)$ $Santech Holdings (STEC.US)$ $Lead Real Estate (LRE.US)$ $Avadel Pharmaceuticals (AVDL.US)$ $Carvana (CVNA.US)$ $Lemonade (LMND.US)$ $Autonomix Medical (AMIX.US)$ $Peloton Interactive (PTON.US)$ $PLBY Group (PLBY.US)$ $Alphatec (ATEC.US)$ $Universal Security Instruments (UUU.US)$ $Biofrontera (BFRI.US)$ $Root Inc (ROOT.US)$
🎃⚡️🎃

EmotionOutOfEquation

Oct 31, 2024 12:16

$Avadel Pharmaceuticals (AVDL.US)$
Given its current financial standing and market movements, Avadel Pharmaceuticals is assessed as a moderately high-risk investment. The company's unprofitability, negative cash flow, and strong dependency on news-related catalysts pose potential risks. Nonetheless, the recently improved stock sentiment, coupled with analysts' positive forecasts, suggests some upside potential. The relatively high position in its volatility scale underscores the need for caution,...